Bio Impact Capital LLC Essa Pharma Inc. Transaction History

Bio Impact Capital LLC

  • $641 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
SELL
$1.75 - $3.44 $446,586 - $877,860
-255,192 Reduced 38.61%
405,700 $738,000
Q1 2022

May 13, 2022
SELL
$6.18 - $14.44 $48,179 - $112,574
-7,796 Reduced 1.17%
660,892 $4.08 Million
Q4 2021

Feb 11, 2022
SELL
$7.8 - $14.38 $113,872 - $209,933
-14,599 Reduced 2.14%
668,688 $9.5 Million
Q3 2021

Nov 15, 2021
BUY
$7.76 - $29.37 $5.3 Million - $20.1 Million
683,287 New
683,287 $5.47 Million

Others Institutions Holding EPIX

# of Institutions
35
Shares Held
35.1M
Call Options Held
15.8K
Put Options Held
21K
View Full List

About ESSA Pharma Inc.

EPIX Quotes by TradingView
  • Ticker EPIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 44,073,100
  • Market Cap $72.3M
  • Description
  • ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreem...
More about EPIX
Track This Portfolio

Track Bio Impact Capital LLC Portfolio

Follow Bio Impact Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bio Impact Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bio Impact Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email